<DOC>
	<DOCNO>NCT00229333</DOCNO>
	<brief_summary>The goal present study compare effectiveness active ( S ) -enantiomer citalopram , escitalopram placebo treatment patient depressive syndrome complicate Alzheimer ’ dementia ( AD ) , vascular dementia ( VD ) mix dementia ( MD ) , 8 week double-blind treatment .</brief_summary>
	<brief_title>Study Escitalopram Versus Placebo Treatment Depressive Syndrome Alzheimer ’ Disease , Vascular Dementia , Mixed Vascular Alzheimer ’ Dementia</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Dementia , Vascular</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Subject meet criteria diagnosis Alzheimer ’ dementia , vascular dementia , mixed alzheimer 's vascular dementia , accord Diagnostic Statistical Mental Disorders , Fourth Edition ( DSMIV ) criterion . Subject meet follow criterion depressive syndrome : DSMIV criterion major depressive episode ; Cornell Scale Depression Dementia 18 . The depressive syndrome present least two week precede study entry ( Visit 1 ) . The depressive syndrome must least moderate severity Visit 1 Visit 2 ( cause subject impairment functional capacity ) opinion investigator require pharmacological intervention . Score Mini Mental State Examination ( MMSE ) 1026 Visit 1 Visit 2 . Other possible reason subject ’ depressive symptom , example , medication medical condition ( pain , infection , cancer pancreas , etc . ) , exclude etiology . General Subjects need placebo runin period , and/or caregiver unable comply Study Period I medication extent drug compliance remainder study would compromise determined investigator . Investigators , site personnel directly affiliate study , immediate family . Immediate family define spouse , parent , child sibling , whether biological legally adopt . Diagnostic Schizophrenia Subjects judge clinically serious suicidal risk Visit 1 . Subjects clinically significant psychotic symptom Visit 1 . Subject serious neurological condition AD , VD MD include , limited : traumatic ( headbrain ) dementia , spaceoccupying lesion , relevant structural abnormality brain imaging , etc . Subject underwent CVA 3 month . Subject well current antidepressant drug regimen . Exclusionary Concurrent Historical Illness : Subjects severe hepatic renal insufficiency . Hypo/hyperthyroidism B12 deficiency Exclusionary Concomitant Historical Medications : Participation clinical trial another investigational drug within 30 day prior study entry ( Visit 1 ) and/or concurrent investigational study . Subjects history severe adverse reaction citalopram escitalopram . Concomitant medication specify . Previous treatment escitalopram unless , opinion investigator , patient ’ previous treatment inadequate dose and/or duration provide accurate assessment therapy .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2006</verification_date>
	<keyword>Escitalopram</keyword>
	<keyword>Depression</keyword>
	<keyword>Dementia</keyword>
	<keyword>Treatment</keyword>
	<keyword>Depressive Syndrome Alzheimer ’ Disease</keyword>
	<keyword>Depressive Syndrome Vascular Dementia</keyword>
	<keyword>Depressive Syndrome Mixed Vascular Alzheimer ’ Dementia</keyword>
</DOC>